Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:31:51.226Z.
Calculation as of: 2026-10-06T20:31:51.226Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76fc2c3b696fe1037033af5d10d354cd3b8573abd6cfebee9ff2ae185940ee40
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Disc Medicine, Inc.
Market Cap
$2.37B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.36B
Operating Cash Flow Yield
5.79%
TTM Avg
3.59%
3Y Avg
2.39%
5Y Avg
2.39%
Market Cap
$2.38B
Operating Cash Flow Yield
3.23%
TTM Avg
2.78%
3Y Avg
2.88%
5Y Avg
3.12%
Market Cap
$2.35B
Operating Cash Flow Yield
N/A
TTM Avg
3.18%
3Y Avg
3.18%
5Y Avg
3.18%
Market Cap
$2.34B
Operating Cash Flow Yield
3.05%
TTM Avg
4.86%
3Y Avg
3.70%
5Y Avg
3.00%
Market Cap
$2.43B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.30B
Operating Cash Flow Yield
3.43%
TTM Avg
1.29%
3Y Avg
1.29%
5Y Avg
1.29%
Market Cap
$2.28B
Operating Cash Flow Yield
15.58%
TTM Avg
16.47%
3Y Avg
12.88%
5Y Avg
9.69%
Market Cap
$2.49B
Operating Cash Flow Yield
0.80%
TTM Avg
2.60%
3Y Avg
5.91%
5Y Avg
6.08%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | $2.37B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 5.79% | 3.59% | 2.39% | 2.39% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | 3.23% | 2.78% | 2.88% | 3.12% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | N/A | 3.18% | 3.18% | 3.18% |
| UFP Technologies, Inc. (UFPT)vs › | $2.34B | 3.05% | 4.86% | 3.70% | 3.00% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | N/A | N/A | N/A | N/A |
| Liquidia Corporation (LQDA)vs › | $2.30B | 3.43% | 1.29% | 1.29% | 1.29% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 15.58% | 16.47% | 12.88% | 9.69% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.49B | 0.80% | 2.60% | 5.91% | 6.08% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
